Your browser doesn't support javascript.
loading
[Differential Diagnosis of Pulmonary Hypertension Using the Example of Collagenosis-associated PAH in the Context of Chronic Lung and Left Heart Disease]. / Differenzialdiagnostik der pulmonalen Hypertonie am Beispiel der Kollagenose assoziierten PAH im Kontext chronischer Lungen- und Linksherzerkrankungen.
Leuchte, H H; Halank, M; Held, M; Borst, M; Ewert, R; Klose, H; Lange, T J; Meyer, F J; Skowasch, D; Wilkens, H; Seyfarth, H-J.
Afiliación
  • Leuchte HH; Klinik der Barmherzigen Schwestern, Krankenhaus Neuwittelsbach, Lehrkrankenhaus der LMU München, Mitglied des DZL.
  • Halank M; Universitätsklinikum Carl Gustav Carus, Medizinische Klinik 1, Bereich Pneumologie, Dresden.
  • Held M; Klinikum Würzburg Mitte, Standort Missioklinik, Medizinische Klinik mit Schwerpunkt Pneumologie und Beatmungsmedizin, Würzburg.
  • Borst M; Medizinische Klinik 1 Caritas-Krankenhaus Bad Mergentheim gemeinnützige GmbH, Bad Mergentheim.
  • Ewert R; Universitätsmedizin Greifswald. Klinik für Innere Medizin B, Bereich Pneumologie, Greifswald.
  • Klose H; Universitätsklinikum Hamburg-Eppendorf, Abteilung für Pneumologie, Hamburg.
  • Lange TJ; Uniklinik Regensburg, Klinik für Innere Medizin II, Bereich Pneumologie, Regensburg.
  • Meyer FJ; Lungenzentrum München (Bogenhausen-Harlaching), München Klinik gGmbH, München.
  • Skowasch D; Universitätsklinikum Bonn, Medizinische Klinik II, Sektion Pneumologie, Bonn.
  • Wilkens H; Pneumologie, Uniklinik Homburg, Homburg.
  • Seyfarth HJ; Bereich Pneumologie, Universitätsklinikum Leipzig, Leipzig.
Pneumologie ; 75(2): 122-137, 2021 Feb.
Article en De | MEDLINE | ID: mdl-33578434
ABSTRACT
Pulmonary hypertension (PH) can be diagnosed in the context of connective tissue diseases (CTD) as well as in elderly patients with multiple comorbidities. A correct clinical differential diagnosis and classification is essential before adequate therapeutic decisions can be made. Differential diagnosis of PH in CTD comprises associated pulmonary arterial hypertension (APAH), group 2 or 3 PH (PH arising from left heart or chronic lung disease), chronic thromboembolic PH (PH) and group 5 (e. g. in the context of terminal renal insufficiency). This is also true of elderly patients in whom the decision has to be made if the increasing number of coincident diseases lead to PH or have to be interpreted as comorbidities. In this manuscript, the differential diagnosis of PH is elucidated, focusing on CTD, in the context of left heart disease and chronic lung disease. Furthermore, criteria are presented facilitating an objective approach in this context.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diagnóstico Diferencial / Cardiopatías / Hipertensión Pulmonar / Enfermedades Pulmonares Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: De Revista: Pneumologie Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diagnóstico Diferencial / Cardiopatías / Hipertensión Pulmonar / Enfermedades Pulmonares Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: De Revista: Pneumologie Año: 2021 Tipo del documento: Article